You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Casodex monotherapy

Showing 51 - 75 of 3,453
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Changsha (BEBT-209 capsules, Letrozole tablets, Fulvestrant)

Active, not recruiting
  • Advanced Breast Cancer
  • BEBT-209 capsules
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Sep 14, 2023

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,

Recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • Birmingham, Alabama
  • +14 more
Oct 11, 2022

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

HIV Trial in Worldwide (VH4004280, VH4011499, VH4004280 Matching Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +42 more
Sep 12, 2023

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

DLBCL Trial in Japan (MT-2111)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Nagoya-shi, Aichi, Japan
  • +3 more
Jan 12, 2023

T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

Not yet recruiting
  • T-cell Lymphoma
  • CLL/SLL
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2023

Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab

Active, not recruiting
Has Results
  • Urothelial Bladder Cancer
  • +2 more
  • Tremelimumab monotherapy
  • +2 more
  • San Francisco, California
  • +13 more
Jan 20, 2023

NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • BNT116
  • +2 more
  • Baltimore, Maryland
  • +14 more
Dec 19, 2022

Advanced / Metastatic Solid Tumor Trial (SR-8541A)

Not yet recruiting
  • Advanced / Metastatic Solid Tumor
  • (no location specified)
Oct 3, 2023

Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • (no location specified)
Jul 25, 2022

Advanced Solid Malignancies Trial in United Kingdom, United States (CT7001, CT7001 in combination with fulvestrant, CT7001 (in

Completed
  • Advanced Solid Malignancies
  • CT7001
  • CT7001 in combination with fulvestrant
  • Tucson, Arizona
  • +22 more
Jan 26, 2023

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine

Not yet recruiting
  • Essential Hypertension
  • Azilsartan Medoxomil Potassium Tablet
  • +2 more
  • (no location specified)
Jul 21, 2023

Advanced Solid Tumors Trial in China (SPH4336, Cadonilimab)

Not yet recruiting
  • Advanced Solid Tumors
  • Fuzhou, Fujian, China
  • +15 more
Jul 12, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • PD-1 inhibitor
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 9, 2023

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

Based on French National Health Insurance Database in Psychotic

Not yet recruiting
  • Psychotic Disorders
  • No Intervention
  • (no location specified)
Nov 21, 2022

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)

Recruiting
  • Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Olaparib 150 MG
  • Modena, Italy
    Aou Modena
Oct 5, 2023

Seasonal Allergic Rhinitis Trial in Toronto (Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride)

Not yet recruiting
  • Seasonal Allergic Rhinitis
  • Mometasone + Azelastine
  • +2 more
  • Toronto, Ontario, Canada
    Sandoz Investigational Site
May 24, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-96673)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Minneapolis, Minnesota
  • +11 more
Nov 18, 2022

Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Mar 29, 2023